Jiang L D, Ma L L, Xue Y, Pan X, He L, Zhao Yan
Department of Rheumatology, Zhongshan Hospital, Fudan University, Evidence-Based Medicine Center, Fudan University, Shanghai 200032, China.
Department of Rheumatology, Huashan Hospital, Fudan University, Shanghai 200040, China.
Zhonghua Nei Ke Za Zhi. 2022 May 1;61(5):517-524. doi: 10.3760/cma.j.cn112138-20211120-00831.
Takayasu's arteritis (TAK) mainly involves the aorta and its major branches, which is characterized as a chronic, progressive and inflammatory disease. China belongs to one of the regions with a high prevalence of TAK referring to its global distribution. However, it is insufficient for the spread and update of standardized diagnosis and treatment of TAK. Based on the evidence and guidelines from China and other countries, Chinese Rheumatology Association developed the standardized diagnosis and treatment of TAK in China. The purpose is to standardize the methods for diagnosis of TAK, assessment of disease activity and disease severity, strategies of internal treatment and timing of surgical intervention, and further leading to protect the function of important organs and improve the disease prognosis.